1. "Marcel Van Den Brink"
  2. "Gunjan Shah"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (8)
Groups
  1. Bone Marrow Transplant (31)
  2. Center for Hematologic Malignancies (31)
  3. Department of Medicine (31)
  4. Executive Committee, Center for Hematologic Malignancies (31)
  5. GSK Faculty (31)
  6. Hematologic Malignancies, Division of (31)

More Groups

People
  1. Gunjan Shah (31)
  2. Marcel Van Den Brink (31)
  3. Sergio Giralt (29)
  4. Michael Scordo (24)
  5. Miguel-Angel Perales (23)
  6. Sean Devlin (21)

More People

Years
  1. 2023 (2)
  2. 2022 (8)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (5)
  6. 2018 (7)

More Years

Publications
  1. Blood (10)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Bone Marrow Transplantation (3)
  4. Clinical Lymphoma, Myeloma and Leukemia (3)
  5. Blood Advances (1)
  6. Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (12)
  2. American Society of Hematology (11)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A reproducible inflammatory biomarker signature identifies non-Hodgkin lymphoma patients at high risk of CAR-T treatment failure across different cohorts
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fei, T.; Fein, J.; Tomas, A. A.; De LaPuerta, M. C.; Dahi, P.; Danylesko, I.; Epstein-Peterson, Z.; Fried, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) study
    Meeting Abstract

    Shah, U. A.; Castro, F.; Anuraj, A.; Schach, E.; Derkach, A.; Joseph, N. S.; Adintori, P. A.; Guttentag, L.; Blaslov, J.; Cross, J. R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM patients with elevated BMI is feasible and associated with improvements in metabolic and microbiome biomarkers of progression
    Meeting Abstract

    Shah, U. A.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Tran, L.; Adintori, P. A.; Burge, M.; Funkhouser, S.; Hosszu, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier plant-based diets
    Journal Article

    Shah, U. A.; Maclachlan, K. H.; Derkach, A.; Salcedo, M.; Barnett, K.; Caple, J.; Blaslov, J.; Tran, L.; Ciardiello, A.; Burge, M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Adintori, P. A.; Knezevic, A.; Devlin, S. M.; Buchan, M. L.; Preston, E. V.; Lin, A. P.; Rodriguez, N. T.; Carino, C. A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index: A new tool for prediction of nonrelapse mortality in allo-HCT
    Journal Article

    Shouval, R.; Fein, J. A.; Cho, C.; Avecilla, S. T.; Ruiz, J.; Alarcon Tomas, A.; Sanchez-Escamilla, M.; Castillo Flores, N.; Yáñez, L.; Barker, J. N.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy
    Journal Article

    Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save